Stout Robert D, Jiang Chuancang, Matta Bharati, Tietzel Illya, Watkins Stephanie K, Suttles Jill
Department of Microbiology and Immunology, University of Louisville School of Medicine, Health Sciences Center, Louisville, KY 40292, USA.
J Immunol. 2005 Jul 1;175(1):342-9. doi: 10.4049/jimmunol.175.1.342.
Recent studies have described the development of distinct functional subsets of macrophages in association with cancer, autoimmune disease, and chronic infections. Based on the ability of Th1 vs Th2 cytokines to promote opposing activities in macrophages, it has been proposed that macrophages develop into either type 1 inflammatory or type 2 anti-inflammatory subsets. As an alternative to the concept of subset development, we propose that macrophages, in response to changes in their tissue environment, can reversibly and progressively change the pattern of functions that they express. As demonstrated herein, macrophages can reversibly shift their functional phenotype through a multitude of patterns in response to changes in cytokine environment. Macrophages display distinct functional patterns after treatment with IFN-gamma, IL-12, IL-4, or IL-10 and additional functional patterns are displayed depending on whether the cytokine is present alone or with other cytokines and whether the cytokines are added before or concomitantly with the activating stimulus (LPS). Sequential treatment of macrophages with multiple cytokines results in a progression through multiple functional phenotypes. This ability to adapt to changing cytokine environments has significant in vivo relevance, as evidenced by the demonstration that macrophage functional phenotypes established in vivo in aged or tumor-bearing mice can be altered by changing their microenvironment. A concept of functional adaptivity is proposed that has important implications for therapeutic targeting of macrophages in chronic diseases that result in the dominance of particular functional phenotypes of macrophages that play a significant role in disease pathology.
最近的研究描述了与癌症、自身免疫性疾病和慢性感染相关的巨噬细胞不同功能亚群的发展。基于Th1与Th2细胞因子在巨噬细胞中促进相反活性的能力,有人提出巨噬细胞可发展为1型炎症亚群或2型抗炎亚群。作为亚群发展概念的替代方案,我们提出巨噬细胞可根据其组织环境的变化,可逆且逐步地改变其表达的功能模式。如本文所示,巨噬细胞可通过多种模式可逆地改变其功能表型,以响应细胞因子环境的变化。在用干扰素-γ、白细胞介素-12、白细胞介素-4或白细胞介素-10处理后,巨噬细胞表现出不同的功能模式,并且根据细胞因子是单独存在还是与其他细胞因子一起存在,以及细胞因子是在激活刺激(脂多糖)之前还是与之同时添加,还会表现出其他功能模式。用多种细胞因子对巨噬细胞进行序贯处理会导致其经历多种功能表型的转变。这种适应不断变化的细胞因子环境的能力在体内具有重要意义,这一点已通过以下证明得到证实:在老年或荷瘤小鼠体内建立的巨噬细胞功能表型可通过改变其微环境而改变。我们提出了功能适应性的概念,这对于在慢性疾病中对巨噬细胞进行治疗靶向具有重要意义,这些慢性疾病会导致在疾病病理学中起重要作用的特定巨噬细胞功能表型占主导地位。